UPC
Universe Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$3.76
−4.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.34x
- Price / sales
- 1.06x
- Price / cash flow
- -1.59x
Enterprise value
- Enterprise value
- -$604.7K
- EV / sales
- -0.03x
- EV / EBITDA
- 0.46x
- EV / EBIT
- 0.29x
- Market cap
- $18.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026